These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27427465)

  • 21. EUCAST invite comments on new methods for antimicrobial susceptibility testing of anaerobic bacteria.
    Kahlmeter G; Morris TE
    Anaerobe; 2021 Aug; 70():102417. PubMed ID: 34314866
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties.
    White BK; Mende K; Weintrob AC; Beckius ML; Zera WC; Lu D; Bradley W; Tribble DR; Schnaubelt ER; Murray CK;
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):144-50. PubMed ID: 26607420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Apr; 43(2):139-42. PubMed ID: 11217270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibility profiles of anaerobic pathogens in The Netherlands.
    Veloo AC; van Winkelhoff AJ
    Anaerobe; 2015 Feb; 31():19-24. PubMed ID: 25192966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of correlation between in vitro susceptibility data of anaerobes to ceftizoxime and clinical response.
    Wikler MA; Moonsammy GI; Nichols RL
    J Chemother; 1989 Jul; 1(4 Suppl):660-1. PubMed ID: 16312580
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial treatment of anaerobic infections.
    Brook I
    Expert Opin Pharmacother; 2011 Aug; 12(11):1691-707. PubMed ID: 21506900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and antimicrobial susceptibility of obligate anaerobic bacteria from clinical samples of animal origin.
    Mayorga M; Rodríguez-Cavallini E; López-Ureña D; Barquero-Calvo E; Quesada-Gómez C
    Anaerobe; 2015 Dec; 36():19-24. PubMed ID: 26385434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades.
    Boyanova L; Kolarov R; Mitov I
    Anaerobe; 2015 Feb; 31():4-10. PubMed ID: 24875330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and antimicrobial susceptibility of anaerobes from patients with periodontal abscess in China.
    He J; Chang Q; Hu F; Feng X; Zhu D; Yu L
    J Antibiot (Tokyo); 2013 Feb; 66(2):97-8. PubMed ID: 23168405
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Jul; 43(3):281-4. PubMed ID: 11218673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anaerobic bacteria in various infections and their antibiotic susceptibility patterns].
    Tunçkanat F; Günalp A
    Mikrobiyol Bul; 1986 Oct; 20(4):230-41. PubMed ID: 3657617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically significant anaerobic bacteria isolated from patients in a South African academic hospital: antimicrobial susceptibility testing.
    Naidoo S; Perovic O; Richards GA; Duse AG
    S Afr Med J; 2011 Sep; 101(10):732, 734. PubMed ID: 22272862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():4-12. PubMed ID: 21728084
    [No Abstract]   [Full Text] [Related]  

  • 35. Chapter 1-3. Anaerobic infections (general): drug susceptibility tests.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():26-30. PubMed ID: 21728086
    [No Abstract]   [Full Text] [Related]  

  • 36. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
    Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
    J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infections caused by anaerobes and antibiotic resistance].
    Arbo-Sosa A; Alpuche-Aranda C
    Bol Med Hosp Infant Mex; 1989 Jul; 46(7):445-7. PubMed ID: 2765157
    [No Abstract]   [Full Text] [Related]  

  • 38. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
    Jang SS; Breher JE; Dabaco LA; Hirsh DC
    J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.